← Back to headlines
Global Pharmaceutical Companies Announce Drug Pricing Agreements Under Trump Administration
A factbox review highlights numerous international pharmaceutical firms that have publicly committed to drug pricing terms negotiated under the current administration.
1 Sept, 14:00 — 1 Sept, 14:00
Sources
Showing 1 of 1 sources
Related Stories
Japan and U.S. Advance $550 Billion Investment Pact Focused on AI and Chips
58m ago
Anthropic Delays AI Startup IPO to Mid-October Amid Credit Facility Deal
2h ago
Trade Negotiations Stall as U.S. Halts Antitrust Cooperation With Canada
2h ago
Corporate Executives Across Various Sectors Sell Company Stock
2h ago